Celebrating PN awareness week May 4-10, 2025

eNews April 2025

ENEWS

Advocacy Day & the critical need for research dollars On March 18, FPN staff and board members traveled to Washington, D.C. to speak up for the 30 million Americans who have peripheral neuropathy (PN). Our visit was urgent because earlier in March, the U.S. Congress passed a bill that cut funding for medical research by 57%. Read […]

Read More… from eNews April 2025

eNews March 2025

ENEWS

Protect PN research from proposed funding cuts Proposed cuts to federal research funding threaten critical studies across many conditions, including neuropathy. Research funding, which totals billions annually, supports essential work on nerve regeneration, pain management, and new treatments for PN. As soon as today, the House will be voting on a continuing resolution to fund […]

Read More… from eNews March 2025

eNews February 2025

ENEWS

FPN funds scholarship award on CIPN Tiffany Li, PhD, has been awarded the 2025 Clinical Research Training Scholarship (CRTS) to support her important research on chemotherapy-induced peripheral neuropathy (CIPN). The CRTS is a multi-year scholarship program providing funding for emerging experts in neuropathy, supporting their efforts to advance treatments, prevention, or cures for neuropathy. Read […]

Read More… from eNews February 2025

eNews March 2024

E-news

As the chilly winds of winter give way to the gentle warmth of spring, we find ourselves amidst a season of transformation and renewal. With each new bud and blossom, we are reminded of the potential for growth and progress in the field of neuropathy research. Please join us as we look forward to brighter […]

Read More… from eNews March 2024

FPN Funds IMAGiNe Study for anti-MAG Research

FPN Funds IMAGiNe Study for anti-MAG Research

Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $24,750 was spent, […]

Read More… from FPN Funds IMAGiNe Study for anti-MAG Research

eNews December 2023

E-news

Happiest of holidays to you and yours from the Foundation for Peripheral Neuropathy. We are so grateful for your continued support in our organization, whether you already made your gift to our year end campaign, told someone about us on Giving Tuesday or recently received your PN swag. Thank you and stay safe, cozy and healthy during this season! […]

Read More… from eNews December 2023

TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING

Anti-MAG neuropathy

Introduction to Anti-MAG Neuropathy Anti-MAG neuropathy refers to a rare auto-immune associated cause of peripheral neuropathy (PN). In this case, the person’s own immune system (specifically, the IgM monoclonal antibodies) attack nerve cells required for a healthy peripheral nervous system – resulting in a slowly progressive and debilitating condition. Patients often experience loss of mobility, […]

Read More… from TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING

Study Protocol on IgM Anti-Mag Neuropathy Released

Advancing Peripheral Neuropathy

The Foundation for Peripheral Neuropathy (FPN) is pleased that the IMAGiNe study protocol has been approved for publication in the Journal of the Peripheral Nervous System. The focus of this international study is a rare autoimmune cause of PN. It is identified by high levels of the IgM protein in the blood of affected patients, […]

Read More… from Study Protocol on IgM Anti-Mag Neuropathy Released

FPN Funding Contributes $90,000 to IMAGiNe Study for anti-MAG Research

Imagine blog

Through the generosity of our donors, we’re able to support the IMAGiNe study with a $150,000 research grant to fund new patient enrollment. $90,000 of these funds, spent in 2022, resulted in over 150 new patients enrolling in the study. The IMAGiNe Study The IMAGiNe study is an international research collaborative focused on patients with […]

Read More… from FPN Funding Contributes $90,000 to IMAGiNe Study for anti-MAG Research

Anti-MAG Peripheral Neuropathy: Q&A

Q&A

Anti-MAG peripheral neuropathy (Immunoglobulin M(IgM) Anti-Myelin Associated Glycoprotein Peripheral Neuropathy) is a rare autoimmune variety of peripheral neuropathy. In this type of PN, a person’s own immune system attacks cells that are specific in maintaining a healthy peripheral nervous system. As these cells are destroyed by antibodies, they lose function and create problems in both […]

Read More… from Anti-MAG Peripheral Neuropathy: Q&A